Evidence map›Paper›PMID 35588499›Full record

ArticleBlood advances2022

Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression.

Samantha A M Tromp, Marijn A Gillissen, Sophie J Bernelot Moens, Ester M M van Leeuwen, Machiel H Jansen, Lianne Koens, Caroline E Rutten, Taco W Kuijpers

Abstract read
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. GermlineHaematologica · 2023
    Pooled it
  2. Article
  3. The Putative Role ofInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Case Report:Frontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Samantha A M TrompDepartment of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital.
Marijn A GillissenDepartment of Hematology, and.
Sophie J Bernelot MoensDepartment of Hematology, and.
Ester M M van LeeuwenDepartment of Experimental Immunology, Amsterdam Institute for Infection and Immunity.
Machiel H JansenDepartment of Experimental Immunology, Amsterdam Institute for Infection and Immunity.
Lianne KoensDepartment of Pathology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Caroline E RuttenDepartment of Hematology, and.
Taco W KuijpersDepartment of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital.ORCID 0000-0002-7421-3370

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis A Virus Cellular Receptor 2Hepatitis A Virus Cellular Receptor 2

Identifiers

PMID35588499
PMCPMC9636311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.